Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for PDEX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 30.74%
December 31, 2025 30.77%
September 30, 2025 31.01%
June 30, 2025 19.96%
March 31, 2025 35.17%
December 31, 2024 30.20%
September 30, 2024 34.58%
June 30, 2024 27.91%
March 31, 2024 28.71%
December 31, 2023 22.55%
September 30, 2023 32.22%
June 30, 2023 31.63%
March 31, 2023 28.55%
December 31, 2022 23.75%
September 30, 2022 26.66%
June 30, 2022 27.78%
March 31, 2022 30.85%
December 31, 2021 33.46%
September 30, 2021 34.32%
June 30, 2021 33.06%
March 31, 2021 37.35%
December 31, 2020 33.61%
September 30, 2020 40.45%
June 30, 2020 38.54%
March 31, 2020 37.73%
Date Value
December 31, 2019 35.98%
September 30, 2019 38.40%
June 30, 2019 36.30%
March 31, 2019 33.02%
December 31, 2018 35.15%
September 30, 2018 39.43%
June 30, 2018 38.24%
March 31, 2018 36.11%
December 31, 2017 31.38%
September 30, 2017 36.03%
June 30, 2017 35.70%
March 31, 2017 35.25%
December 31, 2016 31.64%
September 30, 2016 28.88%
June 30, 2016 25.57%
March 31, 2016 26.31%
December 31, 2015 28.64%
September 30, 2015 26.04%
June 30, 2015 27.84%
March 31, 2015 29.27%
December 31, 2014 30.48%
September 30, 2014 31.71%
June 30, 2014 28.98%
March 31, 2014 22.46%
December 31, 2013 21.40%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%
Baxter International, Inc. 33.55%

Gross Profit Margin (Quarterly) Related Metrics